High overall CRC diagnostic accuracy for home stool test

February 4, 2014
High overall CRC diagnostic accuracy for home stool test

(HealthDay)—Fecal immunochemical tests (FITs) have moderate sensitivity, high specificity, and high overall diagnostic accuracy for detecting colorectal cancer (CRC), according to research published in the Feb. 4 issue of the Annals of Internal Medicine.

Jeffrey K. Lee, M.D., of the University of California in San Francisco, and colleagues conducted a systematic review and meta-analysis of the literature to assess the of FITs for detecting CRC in asymptomatic, average-risk adults.

The researchers found that, for CRC screening, the overall diagnostic accuracy of FITs was 95 percent (95 percent confidence interval [CI], 93 to 97 percent), the pooled sensitivity was 0.79 (95 percent CI, 0.69 to 0.86), and the pooled specificity was 0.94 (95 percent CI, 0.92 to 0.95). Using a lower assay cutoff value for a positive test result, such as less than 20 µg/g, improved sensitivity to 0.89 (95 percent CI, 0.80 to 0.95) but decreased specificity.

"FITs are moderately sensitive, are highly specific, and have high overall diagnostic accuracy for detecting CRC. Diagnostic performance of FITs depends on the cutoff value for a positive test result," the authors conclude. "Health systems wishing to optimize use of a quantitative FIT should consider the tradeoff between increasing sensitivity (by lowering the cutoff threshold for a positive test) and the resulting increase in the number of positive test results, which will have a greater effect on colonoscopy resources."

Explore further: Osteoporosis / Osteopenia prevalent in chronic pancreatitis

More information: Full Text

Related Stories

Osteoporosis / Osteopenia prevalent in chronic pancreatitis

January 31, 2014
(HealthDay)—Sixty-five percent of patients with chronic pancreatitis have osteoporosis or osteopenia, according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology.

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014
(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

Neurological testing limited in diagnosing disc herniation

June 17, 2013
(HealthDay)—Neurological testing procedures have limited diagnostic accuracy for detecting disc herniation with suspected radiculopathy, according to a review and meta-analysis published in the June issue of The Spine Journal.

Combination protocol accurately diagnoses appendicitis in kids

January 5, 2014
(HealthDay)—A clinical pathway combining the Samuel's pediatric appendicitis score (PAS) and selective use of ultrasonography (US) has high sensitivity and specificity for diagnosing appendicitis in children, according ...

ACG: Physical activity linked to lower risk of esophageal cancer

October 16, 2013
(HealthDay)—Physical activity is associated with a reduced risk of esophageal cancer (EC), according to a review and meta-analysis presented at the annual meeting of the American College of Gastroenterology, held from Oct. ...

Stage III/IV melanoma patients at risk for new primaries

December 10, 2013
(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.